Escleroterapia básica

1) Engel A, Johnson M, Haynes S. Health effects of sunlight exposure in the United States: results from the First National Health and Nutrition Examination Survey 1971–1974. Arch Dermatol 1988;124:72.

2) Kanter A. The effect of sclerotherapy on restless legs syndrome. Dermatol Surg 1992;21:328-32.

3) Isaacs M. Symptomatology of vein disease. Dermatol Surg 1995;21:321-3.

4) Sadick N. Predisoposing factors of varicose and telangiectatic leg veins. J Dermatol Surg Oncol 1992;18:883-6

5) Weiss R, Weiss M. Resolution of pain associated with varicose and telangiectatic leg veins after compression sclerotherapy. J Dermatol Surg Oncol 1990;16:333-6.

6) Bohler-Sommeregger K, Karnel F, Schuller-Petrovic S, Santler R. Do telangiectases commmunicate with the deep venous system? J Dermatol Surg Oncol 1992;18:403-6.

7) Green D. Sclerotherapy for the permanent eradication of varicose veins: theroretical and practical considerations. J Am Acad Dermatol 1998;38:461-75.

8) Vin F, Allaert F, Levardon M. Influence of estrogens and progesterone on the venous system of the lower limbs in women. J Dermatol Surg Oncol 1992;18:888-92.

9) Green D. Mechanism of action of sclerotherapy. Semin Dermatol 1993;12(2):88-97

10) Sadick N. Sclerotherapy of varicose and telangiectatic leg veins: minimal sclerosant concentration of hypertonic saline and its relationship to vessel diameter. J Dermatol Surg Oncol 1991;65-70.

11) Goldman M. Sclerotherapy: treatment of varicose and telangiectatic leg veins, St. Louis, MO: Mosby; 1995.

12) Conrad P, Malouf G, Stacey M. The Australian Polidocanol (Aethosysklerol) Study: results at 2 years. Dermatol Surg 1995;21:334-6.

13) McCoy S, Evans A, Spurrier N. Sclerotherapy for leg telangiectasia—a blinded
comparative trial of polidocanol and hypertonic saline. Dermatol Surg 1999;25:381-6.

14) Goldman M. Treatment of varicose and telangiectatic leg veins: double blind prospective comparative trial between Aethoxyskerol and Sotradecol. Dermatol Surg 2002;28:52-5.

15) Sadick N. Hyperosmolar versus detergent sclerosing agents in sclerotherapy: effect on distal vessel obliteration. J Dermatol Surg Oncol 1994;20:313-6.

16) Goldman M. A comparison of sclerosing agents: clinical and histological effects of intravascular sodium morrhuate, ethanolamine oleate, hypertonic saline (11.7%) and sclerodex in the dorsal rabbit ear vein. J Derm Surg Oncol 1991;17:354-62.

17) Drake L, Dinehart S, Goltz